Nutri Pharma Patent upheld by European Patent Office

Nutri Pharma Patent upheld by European Patent Office European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Bioriginal Europe/Asia Announces 3 New Appointments Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office. Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005 Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005. Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005 Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005. Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005 Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005. Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005 Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005. Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005 Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. BioGaia AB Presents Year-end Report for 2004 Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. Campina Investing in Whey Processing and Food Ingredient Operations Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring. UK: Vitamin and Mineral Dossiers Submitted Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted. UK: Vitamin and Mineral Dossiers Submitted Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted. UK: Vitamin and Mineral Dossiers Submitted Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted. UK: Vitamin and Mineral Dossiers Submitted Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted. UK: Vitamin and Mineral Dossiers Submitted Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted. UK: Vitamin and Mineral Dossiers Submitted Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	The Opposition Division of the European Patent Office has announced that Nutri Pharma’s European Patent, No. 0902624, is valid under the European Patent Convention and has both novelty and inventive merit. The Opposition of Solae LLC, the joint venture between DuPont and Bunge, and the world's leading supplier of isolated soy proteins, was therefore dismissed, although they have the right to appeal. This patent can now be kept in force until 2017, with only minor amendments to the form of a few dependent claims. Protecting the use of compositions containing isolated soy protein and soy fibre for reducing cholesterol, this was the first composition patent to be granted to Nutri Pharma and covers the weight management products sold as Nutrilett® in the Nordic region. "We are delighted that the European Patent Office has upheld our patent. This official endorsement of Nutri Pharma's patent portfolio underlines the company's position in any future patent infringement cases." Trond Syvertsen, CEO For further information on Nutri Pharma and its patented soy technology please visit www.nutripharma.com - Ends -
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software